Boardroom Alpha
10-Q primary document
CEVA · Quarterly Report (Form 10-Q) · Filed August 10, 2026

Ceva Inc10-Q exhibit

ex_1000032.htm
ex_1000032.htm

Exhibit 10.1

 

AMENDMENT TO

CEVA, INC.

2003 DIRECTOR STOCK OPTION PLAN

 

THIS AMENDMENT TO CEVA, INC. 2003 DIRECTOR STOCK OPTION PLAN, AS AMENDED AND RESTATED EFFECTIVE MAY 15, 2007 AND MAY 17, 2011 (this “Amendment”) is made and adopted by the Board of Directors (the “Board”) of Ceva, Inc., a Delaware corporation (the “Corporation”), as of May 7, 2026 (the “Effective Date”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to them in the Plan (as defined below).

 

RECITALS

 

WHEREAS, the Company maintains the Ceva, Inc. 2003 Director Stock Option Plan (as amended and restated effective May 15, 2007 and May 17, 2011, the “Plan”);

 

WHEREAS, pursuant to Section 9 of the Plan, the Plan may be amended or otherwise modified from time to time by the Board; and

 

WHEREAS, the Board desires to amend the Plan as set forth herein.

 

NOW, THEREFORE, BE IT RESOLVED, that the Plan is hereby amended as set forth herein, effective as of the Effective Date.

 

AMENDMENT

 

1.

Section 5(f) of the Plan is hereby amended and restated in its entirety as follows:

 

“(f)         Exercise of Option. An option may be exercised only by written notice to the Company at its principal office accompanied by payment in full, as specified in the immediately following sentence, for the number of shares for which the option is exercised. The exercise price of an option must be paid by: (i) cash or certified or bank check, (ii) an irrevocable undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price or delivery of irrevocable instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price, or (iii) to the extent permitted by the Board, surrendering shares then issuable upon the option’s exercise valued at the closing price of the Common Stock on The NASDAQ Global Market (or any other national securities exchange on which the Common Stock is then listed) on the exercise date.”

 

2.

This Amendment shall be and is hereby incorporated in and forms a part of the Plan.

 

3.

Except as expressly provided herein, all terms and provisions of the Plan shall remain in full force and effect.

 

[Signature Page Follows]

 

 

 

 

I hereby certify that the foregoing Amendment was duly adopted by the Board of Directors of Ceva, Inc. on May 7, 2026.

 

Executed on this 7 day of May 2026.

 

 

  /s/ Dotan Bar-Natan 
 

Name: Dotan Bar-Natan

Title: Chief Legal Officer

 

 

2
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer